| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.85M | $1.81M | $3.18M | $12.09M | $52.45M |
| R&D | $615.92K | $362.54K | $202.88K | $1.10M | $1.22M |
| SG&A | $1.83M | $1.13M | $2.97M | $10.99M | $51.23M |
| Operating Income | -$2.85M | -$1.81M | -$3.18M | -$12.09M | -$52.45M |
| Interest Expense | – | – | – | – | $574.52K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.85M | -$1.81M | -$3.18M | -$12.09M | $10.19M |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | -0.0200 | 0.0200 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | -0.0200 | 0.0000 |
| Shares (diluted) | $721.53M | $704.60M | $705.03M | $705.13M | $1.12B |